Emily M Ringwalt

3PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 08, 2025
Trabectedin Enhances the Antitumor Effects of IL-12 in Triple-Negative Breast Cancer.

Emily Schwarz, Himanshu Savardekar, Sara Zelinskas

|Mar 11, 2024
Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone Sarcoma.

Emily M Ringwalt, Mark A Currier, Andrea M Glaspell

|Sep 07, 2023
Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization.

Camille A McAloney, Rawan Makkawi, Yogesh Budhathoki

Pageof 1